SBRT and IL-12 in PDAC: Local Therapy Alters Bone Marrow Hematopoiesis
Localized SBRT and IL-12 treatment in PDAC showed significant effects on bone marrow, including acute lymphopenia and altered hematopoiesis.
Asset / Drug
Drug and asset intelligence for SBRT with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.